Is combined treatment with fenofibrate and ezetimibe safe and efficacious in patients with mixed hyperlipidemia?

被引：3
|
作者：
Davidson, Michael H.
机构：
[1] Radiant Res, Chicago, IL 60610 USA
[2] Rush Univ, Med Ctr, Chicago, IL USA
来源：
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE | 2006年 / 3卷 / 11期
关键词：
ezetimibe; fenofibrate; hyperlipidemia;
D O I：
10.1038/ncpcardio0689
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：594 / 595
页数：2
相关论文
共 50 条
  • [21] Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of combined hyperlipidemia
    Koh, KK
    Quon, MJ
    Han, SH
    Chung, WJ
    Ahn, JY
    Seo, YH
    Choi, IS
    Shin, EK
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (10) : 1649 - 1653
  • [22] Effects of co-administered Ezetimibe/Simvastatin and fenofibrate on lipoprotein subclasses and LDL size pattern in patients with mixed hyperlipidemia
    Famier, Michel
    Perevozskaya, Inna
    Taggart, William
    Kush, Debra
    Mitchel, Yale
    CIRCULATION, 2006, 114 (18) : 289 - 289
  • [23] Efficacy and safety of the coadministration of ezetimibe with fenofibrate in patients with mixed hyperlipidaemia
    Farnier, M
    Freeman, MW
    Macdonell, G
    Perevozskaya, I
    Davies, MJ
    Mitchel, YB
    Gumbiner, B
    EUROPEAN HEART JOURNAL, 2005, 26 (09) : 897 - 905
  • [24] Comparison of the efficacy of atorvastatin and micronised fenofibrate in the treatment of mixed hyperlipidemia
    Miltiadous, G
    Bairaktari, E
    Tzallas, C
    Tsimihodimos, V
    Liberopoulos, E
    Millionis, H
    Rizos, E
    Elisaf, M
    ATHEROSCLEROSIS, 1999, 144 : 37 - 37
  • [25] Comparison of the efficacy of atorvastatin and micronized fenofibrate in the treatment of mixed hyperlipidemia
    Bairaktari, ET
    Tzallas, CS
    Tsimihodimos, VK
    Liberopoulos, EN
    Miltiadous, GA
    Elisaf, MS
    JOURNAL OF CARDIOVASCULAR RISK, 1999, 6 (02): : 113 - 116
  • [26] The long-term treatment of combined hyperlipidemia in CHD patients with a combination of fluvastatin and fenofibrate
    Widimsky, J
    Hulínsky, V
    Balazovjech, I
    Lánská, V
    ATHEROSCLEROSIS, 1999, 144 : 181 - 181
  • [27] VAP II analysis of lipoprotein subclasses in mixed hyperlipidemic patients on treatment with ezetimibe/simvastatin and fenofibrate
    Farnier, Michel
    Perevozskaya, Inna
    Taggart, William V.
    Kush, Debra
    Mitchel, Yale B.
    JOURNAL OF LIPID RESEARCH, 2008, 49 (12) : 2641 - 2647
  • [28] Effects of the co-administration of ezetimibe/simvastatine and fenofibrate on the lipoproteins sub-classes and on the LDL size profile in patients with mixed hyperlipidemia
    Farnier, M.
    Perevozskaya, I.
    Taggart, W.
    Kush, D.
    Mitchel, Y.
    DIABETES & METABOLISM, 2007, 33 : S59 - S60
  • [29] Ezetimibe in the Treatment of Uncontrolled Hyperlipidemia in Kidney Transplant Patients
    Rodriguez-Ferrero, M. L.
    Anaya, F.
    TRANSPLANTATION PROCEEDINGS, 2008, 40 (10) : 3492 - 3495
  • [30] Effect of co-administration of ezetimibe/simvastatin and fenofibrate on apolipoproteins (A-III, B, and C-III) in patients with mixed hyperlipidemia
    Roth, Eli
    Farnier, Michel
    Perevozskaya, Inna
    Davies, Michael
    Kush, Debra
    Mitchel, Yale
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 325A - 325A
12345